Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
91.85%
Operating Margin
43.42%
Net Margin
24.52%
Efficiency Metrics
Revenue per Expense Ratio
1.80
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
66.27%
Income Tax Rate
0.99%
EPS
1.9800000000
Balance Sheet Analysis
Current Ratio
0.82
Cash Ratio
0.38
Working Capital
$-36.54M
Debt to Equity
1.24
Debt to Assets
53.38%
Equity Ratio
43.05%
Cash Flow Analysis
Operating Cash Flow Ratio
63.36%
Free Cash Flow Ratio
64.05%
CapEx to Revenue
0.69%
Dividends Paid
$272.25M
Stock Buybacks
$3.70M
Total Shareholder Returns
$275.94M
Cash Position Change
-26.72%
Key Takeaways (2023 FY)
Increased dividend payments by 2.08%
Detailed Growth Metrics
Core Performance
Revenue
7.24%
Net Income
-1.81%
EPS
-2.46%
Operating Income
-1.47%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
9.43%
Operating Cash Flow
1.22%
Free Cash Flow
4.39%
Balance Sheet Health
Assets
-1.00%
Debt
-0.28%
Book Value per Share
-3.59%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
2.08%
Shares Outstanding
0.39%
Long Term Trends
3Y Revenue/Share
71.84%
5Y Revenue/Share
-0.59%
3Y Dividend/Share
59.40%
5Y Dividend/Share
-21.49%